OpenURL Connection Search

Select item for more details and to access through your institution.

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.
Published in:
2014
By:
- Kang, Min H.;
- Villablanca, Judith G.;
- Glade Bender, Julia L.;
- Matthay, Katherine K.;
- Groshen, Susan;
- Sposto, Richard;
- Czarnecki, Scarlett;
- Ames, Matthew M.;
- Patrick Reynolds, C.;
- Marachelian, Araz;
- Maurer, Barry J.
Publication type:
Case Study
A Phase I study of concurrent RMP‐7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomasPresented in part at the Child Neurology Society, Ottawa, Canada, October 15, 2004.
Published in:
Cancer (0008543X), 2005, v. 104, n. 9, p. 1968, doi. 10.1002/cncr.21403
By:
- Roger J. Packer;
- Mark Krailo;
- Minesh Mehta;
- Katherine Warren;
- Jeffrey Allen;
- Regina Jakacki;
- Judith G. Villablanca;
- Akiko Chiba;
- Gregory Reaman
Publication type:
Article
Phase 1 study of concurrent RMP‐7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomasPresented, in part, at the 33rd Annual Meeting of the Child Neurology Society, Ottawa, Canada, October 15, 2004.
Published in:
Cancer (0008543X), 2005, v. 104, n. 6, p. 1281, doi. 10.1002/cncr.21301
By:
- Roger J. Packer;
- Mark Krailo;
- Minesh Mehta;
- Katherine Warren;
- Jeffrey Allen;
- Regina Jakacki;
- Judith G. Villablanca;
- Akiko Chiba;
- Gregory Reaman
Publication type:
Article
Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group.
Published in:
Journal of Nuclear Medicine, 2013, v. 54, n. 4, p. 541, doi. 10.2967/jnumed.112.112334
By:
- Yanik, Gregory A.;
- Parisi, Marguerite T.;
- Shulkin, Barry L.;
- Naranjo, Arlene;
- Kreissman, Susan G.;
- London, Wendy B.;
- Villablanca, Judith G.;
- Maris, John M.;
- Park, Julie R.;
- Cohn, Susan L.;
- McGrady, Patrick;
- Matthay, Katherine K.
Publication type:
Article
Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial.
Published in:
Journal of Nuclear Medicine, 2012, v. 53, n. 7, p. 1155, doi. 10.2967/jnumed.111.098624
By:
- Matthay, Katherine K.;
- Weiss, Brian;
- Villablanca, Judith G.;
- Mans, John M.;
- Yanik, Gregory A.;
- DuBois, Steven G.;
- Stubbs, James;
- Groshen, Susan;
- Tsao-Wei, Denice;
- Hawkins, Randall;
- Jackson, Hollie;
- Goodarzian, Fariba;
- Daldrup-Link, Heike;
- Panigrahy, Ashok;
- Towbin, Alexander;
- Shimada, Hiroyuki;
- Barrett, John;
- LaFrance, Norman;
- Babich, John
Publication type:
Article
Expression of neuroblastoma‐related genes in bone marrow at end of high‐risk neuroblastoma therapy.
Published in:
Pediatric Blood & Cancer, 2022, v. 69, n. 9, p. 1, doi. 10.1002/pbc.29719
By:
- Asgharzadeh, Shahab;
- Marachelian, Araz;
- Villablanca, Judith G.;
- Liu, Wei Yao;
- Kennedy, Rebekah;
- Sposto, Richard;
- Naranjo, Arlene;
- Tenney, Sheena;
- Yu, Alice L.;
- Ozkaynak, M. Fevzi;
- Sondel, Paul M.;
- Park, Julie R.;
- Seeger, Robert C.
Publication type:
Article
A safety and feasibility trial of 131I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study.
Published in:
Pediatric Blood & Cancer, 2021, v. 68, n. 10, p. 1, doi. 10.1002/pbc.29117
By:
- Weiss, Brian D.;
- Yanik, Gregory;
- Naranjo, Arlene;
- Zhang, Fan F.;
- Fitzgerald, Wendy;
- Shulkin, Barry L.;
- Parisi, Marguerite T.;
- Russell, Heidi;
- Grupp, Stephan;
- Pater, Luke;
- Mattei, Peter;
- Mosse, Yael;
- Lai, Hollie A.;
- Jarzembowski, Jason A.;
- Shimada, Hiroyuki;
- Villablanca, Judith G.;
- Giller, Roger;
- Bagatell, Rochelle;
- Park, Julie R.;
- Matthay, Katherine K.
Publication type:
Article
A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).
Published in:
2020
By:
- Jubran, Rima F.;
- Villablanca, Judith G.;
- Krailo, Mark;
- Piao, Jin;
- Huang, Li;
- Murphree, A. Linn;
- O'Brien, Joan;
- Gombos, Dan;
- Shields, Carol L.;
- Meadows, Anna;
- Chintagumpala, Murali
Publication type:
journal article
Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature.
Published in:
2020
By:
- Duvalyan, Angela;
- Cha, Angela;
- Goodarzian, Fariba;
- Arkader, Alexandre;
- Villablanca, Judith G.;
- Marachelian, Araz
Publication type:
journal article
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
Published in:
2019
By:
- Braunstein, Steve E.;
- London, Wendy B.;
- Kreissman, Susan G.;
- Villablanca, Judith G.;
- Davidoff, Andrew M.;
- DeSantes, Kenneth;
- Castleberry, Robert P.;
- Murray, Kevin;
- Diller, Lisa;
- Matthay, Katherine;
- Cohn, Susan L.;
- Shulkin, Barry;
- Allmen, Daniel;
- Parisi, Marguerite T.;
- Ryn, Collin;
- Park, Julie R.;
- Quaglia, Michael P.;
- Haas‐Kogan, Daphne A.;
- von Allmen, Daniel;
- Van Ryn, Collin
Publication type:
journal article
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Published in:
2018
By:
- Pinto, Navin;
- DuBois, Steven G.;
- Marachelian, Araz;
- Diede, Scott J.;
- Taraseviciute, Agne;
- Glade Bender, Julia L.;
- Tsao‐Wei, Denice;
- Groshen, Susan G.;
- Reid, Joel M.;
- Haas‐Kogan, Daphne A.;
- Reynolds, C. Patrick;
- Kang, Min H.;
- Irwin, Meredith S.;
- Macy, Margaret E.;
- Villablanca, Judith G.;
- Matthay, Katherine K.;
- Park, Julie R.;
- Tsao-Wei, Denice;
- Haas-Kogan, Daphne A
Publication type:
journal article
Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.
Published in:
2018
By:
- Villablanca, Judith G.;
- Ji, Lingyun;
- Shapira‐Lewinson, Adi;
- Marachelian, Araz;
- Shimada, Hiroyuki;
- Hawkins, Randall A.;
- Pampaloni, Miguel;
- Lai, Hollie;
- Goodarzian, Fariba;
- Sposto, Richard;
- Park, Julie R.;
- Matthay, Katherine K.;
- Shapira-Lewinson, Adi
Publication type:
journal article
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Published in:
2016
By:
- Villablanca, Judith G.;
- Volchenboum, Samuel L.;
- Cho, Hwangeui;
- Kang, Min H.;
- Cohn, Susan L.;
- Anderson, Clarke P.;
- Marachelian, Araz;
- Groshen, Susan;
- Tsao‐Wei, Denice;
- Matthay, Katherine K.;
- Maris, John M.;
- Hasenauer, Charlotte E.;
- Czarnecki, Scarlett;
- Lai, Hollie;
- Goodarzian, Fariba;
- Shimada, Hiro;
- Reynolds, Charles Patrick;
- Tsao-Wei, Denice
Publication type:
journal article
Pilot study of intravenous melphalan combined with continuous infusion L- S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2015, v. 62, n. 10, p. 1739, doi. 10.1002/pbc.25594
By:
- Anderson, Clarke P.;
- Matthay, Katherine K.;
- Perentesis, John P.;
- Neglia, Joseph P.;
- Bailey, Howard H.;
- Villablanca, Judith G.;
- Groshen, Susan;
- Hasenauer, Beth;
- Maris, John M.;
- Seeger, Robert C.;
- Reynolds, C. Patrick
Publication type:
Article
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium.
Published in:
Pediatric Blood & Cancer, 2013, v. 60, n. 11, p. 1801, doi. 10.1002/pbc.24643
By:
- Maurer, Barry J.;
- Kang, Min H.;
- Villablanca, Judith G.;
- Janeba, Jitka;
- Groshen, Susan;
- Matthay, Katherine K.;
- Sondel, Paul M.;
- Maris, John M.;
- Jackson, Hollie A.;
- Goodarzian, Fariba;
- Shimada, Hiroyuki;
- Czarnecki, Scarlett;
- Hasenauer, Beth;
- Reynolds, C. Patrick;
- Marachelian, Araz
Publication type:
Article
Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: The Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
Published in:
Pediatric Blood & Cancer, 2012, v. 58, n. 6, p. 905, doi. 10.1002/pbc.23349
By:
- Gozali, Alexa E.;
- Britt, Barbara;
- Shane, Lisa;
- Gonzalez, Ignacio;
- Gilles, Floyd;
- McComb, J. Gordon;
- Krieger, Mark D.;
- Lavey, Robert S.;
- Shlien, Adam;
- Villablanca, Judith G.;
- Erdreich-Epstein, Anat;
- Dhall, Girish;
- Jubran, Rima;
- Tabori, Uri;
- Malkin, David;
- Finlay, Jonathan L.
Publication type:
Article
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
Published in:
2012
By:
- Marachelian A;
- Shimada H;
- Sano H;
- Jackson H;
- Stein J;
- Sposto R;
- Matthay KK;
- Baker D;
- Villablanca JG;
- Marachelian, Araz;
- Shimada, Hiroyuki;
- Sano, Hideki;
- Jackson, Hollie;
- Stein, James;
- Sposto, Richard;
- Matthay, Katherine K;
- Baker, David;
- Villablanca, Judith G
Publication type:
journal article
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2012, v. 58, n. 5, p. 675, doi. 10.1002/pbc.23250
By:
- Marachelian, Araz;
- Shimada, Hiroyuki;
- Sano, Hideki;
- Jackson, Hollie;
- Stein, James;
- Sposto, Richard;
- Matthay, Katherine K.;
- Baker, David;
- Villablanca, Judith G.
Publication type:
Article
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study.
Published in:
Pediatric Blood & Cancer, 2011, v. 57, n. 2, p. 275, doi. 10.1002/pbc.22821
By:
- Russell, Heidi V.;
- Groshen, Susan G.;
- Ara, Tasnim;
- DeClerck, Yves A.;
- Hawkins, Randy;
- Jackson, Hollie A.;
- Daldrup-Link, Heike E.;
- Marachelian, Araz;
- Skerjanec, Andrej;
- Park, Julie R.;
- Katzenstein, Howard;
- Matthay, Katherine K.;
- Blaney, Susan M.;
- Villablanca, Judith G.
Publication type:
Article
Thyroid and hepatic function after high-dose 131I-metaiodobenzylguanidine (131I-MIBG) therapy for neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2011, v. 56, n. 2, p. 191, doi. 10.1002/pbc.22767
By:
- Quach, Alekist;
- Ji, Lingyun;
- Mishra, Vikash;
- Sznewajs, Aimee;
- Veatch, Janet;
- Huberty, John;
- Franc, Benjamin;
- Sposto, Richard;
- Groshen, Susan;
- Wei, Denice;
- Fitzgerald, Paul;
- Maris, John M.;
- Yanik, Gregory;
- Hawkins, Randall A.;
- Villablanca, Judith G.;
- Matthay, Katherine K.
Publication type:
Article
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Published in:
Pediatric Blood & Cancer, 2010, v. 55, n. 1, p. 42, doi. 10.1002/pbc.22468
By:
- Khatua, Soumen;
- Dhall, Girish;
- O'Neil, Sharon;
- Jubran, Rima;
- Villablanca, Judith G.;
- Marachelian, Araz;
- Nastia, Arti;
- Lavey, Robert;
- Olch, Arthur J.;
- Gonzalez, Ignacio;
- Gilles, Floyd;
- Nelson, Marvin;
- Panigrahy, Ashok;
- McComb, Gordon;
- Krieger, Mark;
- Fan, Jing;
- Sposto, Richard;
- Finlay, Jonathan L.
Publication type:
Article
Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: A report from the Childrens Oncology Group.
Published in:
Pediatric Blood & Cancer, 2010, v. 54, n. 4, p. 596, doi. 10.1002/pbc.22344
By:
- Bensimhon, Pamela;
- Villablanca, Judith G.;
- Sender, Leonard S.;
- Matthay, Katherine K.;
- Park, Julie R.;
- Seeger, Robert;
- London, Wendy B.;
- Yap, John Stephen F.;
- Kreissman, Susan G.
Publication type:
Article
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
Published in:
2009
By:
- Park JR;
- Villablanca JG;
- London WB;
- Gerbing RB;
- Haas-Kogan D;
- Adkins ES;
- Attiyeh EF;
- Maris JM;
- Seeger RC;
- Reynolds CP;
- Matthay KK;
- Park, Julie R;
- Villablanca, Judith G;
- London, Wendy B;
- Gerbing, Robert B;
- Haas-Kogan, Daphne;
- Adkins, E Stanton;
- Attiyeh, Edward F;
- Maris, John M;
- Seeger, Robert C
Publication type:
journal article
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13- cis-retinoic acid: A report from the Children's Oncology Group.
Published in:
Pediatric Blood & Cancer, 2009, v. 52, n. 1, p. 44, doi. 10.1002/pbc.21784
By:
- Park, Julie R.;
- Villablanca, Judith G.;
- London, Wendy B.;
- Gerbing, Robert B.;
- Haas-Kogan, Daphne;
- Adkins, E. Stanton;
- Attiyeh, Edward F.;
- Maris, John M.;
- Seeger, Robert C.;
- Reynolds, C. Patrick;
- Matthay, Katherine K.
Publication type:
Article
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
Published in:
2022
By:
- Park, Julie R.;
- Villablanca, Judith G.;
- Hero, Barbara;
- Kushner, Brian H.;
- Wheatley, Keith;
- Beiske, Klaus H.;
- Ladenstein, Ruth L.;
- Baruchel, Sylvain;
- Macy, Margaret E.;
- Moreno, Lucas;
- Seibel, Nita L.;
- Pearson, Andrew D.;
- Matthay, Katherine K.;
- Valteau‐Couanet, Dominique;
- Valteau-Couanet, Dominique
Publication type:
journal article

Found: 25

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.

A Phase I study of concurrent RMP‐7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomasPresented in part at the Child Neurology Society, Ottawa, Canada, October 15, 2004.

Phase 1 study of concurrent RMP‐7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomasPresented, in part, at the 33rd Annual Meeting of the Child Neurology Society, Ottawa, Canada, October 15, 2004.

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group.

Dose Escalation Study of No-Carrier-Added <sup>131</sup>I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial.

Expression of neuroblastoma‐related genes in bone marrow at end of high‐risk neuroblastoma therapy.

A safety and feasibility trial of <sup>131</sup>I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study.

A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231).

Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature.

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.

Pilot study of intravenous melphalan combined with continuous infusion L- S,R-buthionine sulfoximine for children with recurrent neuroblastoma.

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium.

Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: The Children's Hospital Los Angeles (CHLA) experience, 1991-2010.

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study.

Thyroid and hepatic function after high-dose <sup>131</sup>I-metaiodobenzylguanidine (<sup>131</sup>I-MIBG) therapy for neuroblastoma.

Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.

Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: A report from the Childrens Oncology Group.

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13- cis-retinoic acid: A report from the Children's Oncology Group.

Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.